Baseline splenic volume as a biomarker for clinical outcome and circulating lymphocyte count in gastric cancer

HIGHLIGHTS

  • who: Ziyang Zeng and collaborators from the Zhejiang Cancer Hospital, University of (CAS), China have published the research work: Baseline splenic volume as a biomarker for clinical outcome and circulating lymphocyte count in gastric cancer, in the Journal: (JOURNAL)
  • what: Consistent with a large cohort study of the prognostic effect of BMI in gastric cancer , the survival curves in the study showed that the overweight patients were associated with more favorable clinical outcome, followed by normalweight and underweight patients .
  • how: To allow comparisons of high and low splenic volume only made within patients . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?